DOI: 10.1038/CLPT.2010.208
Increased clinicalresearch is being carried out in developing countries, where there aredifficulties in adhering to the same ethical principles that governresearch in the developed world. The recent revelation that anexploitative experiment funded by the U.S. government was conducted inGuatemala in the 1940s is just one example of these issues. Well-intentioned research policies have been created to prevent humanrights violations, but these are not perfectly transferable to researchstudies in very poor nations. True informed consent may not beobtainable due to the subjects’ lack of understanding, dire livingconditions, or deference to religious leaders or family members. Given the difficulties of policy implementation, Caplan suggests that itis as important to decide “what will be given to those involved inresearch and their countrymen at the conclusion of clinical research asit is to battle over the nuances of research ethics requirements thatcannot in fact be implemented or monitored in any practical sense.” Byresearchers giving back to their trial subjects, an exploitativesituation – one in which those bearing all the risks receive none of thebenefits – would be avoided. However, the benefits would have to betailored to the needs and values of the receiving community and wouldhave to be monitored for efficacy.
Author contact:
Arthur Caplan, PhD (Center for Bioethics, University of Pennsylvania, Philadelphia, PA, USA)
Tel: +1 215 898 7136
E-mail: [email protected]
Editorial contact:
Sharon Swan, CAE (American Society of Clinical Pharmacology and Therapeutics, Alexandria, VA, USA)
Tel: +1 703 836 6981
E-mail: [email protected]
Press contact: Ruth Francis (Nature London)
Tel: +44 20 7843 4562
E-mail: [email protected]
About Nature Publishing Group (NPG)
Nature Publishing Group (NPG) is a publisher of high impact scientificand medical information in print and online. NPG publishes journals,online databases and services across the life, physical, chemical andapplied sciences and clinical medicine.
Focusing on the needs of scientists, Nature (founded in 1869) is theleading weekly, international scientific journal. In addition, for thisaudience, NPG publishes a range of Nature research journals and Nature Reviews journals, plus a range of prestigious academic journalsincluding society-owned publications. Online, nature.com provides over 5million visitors per month with access to NPG publications and onlinedatabases and services, including Nature News and NatureJobs plusaccess to Nature Network and Nature Education’s Scitable.com.
Scientific American is at the heart of NPG’s newly-formed consumermedia division, meeting the needs of the general public. Founded in1845, Scientific American is the oldest continuously publishedmagazine in the US and the leading authoritative publication for sciencein the general media. Together with scientificamerican.com and 15 locallanguage editions around the world it reaches over 3 million consumersand scientists. Other titles include Scientific American Mind and Spektrum der Wissenschaft in Germany.
Throughout all its businesses NPG is dedicated to serving the scientificand medical communities and the wider scientifically interested generalpublic. Part of Macmillan Publishers Limited, NPG is a global companywith principal offices in London, New York and Tokyo, and offices incities worldwide including Boston, Buenos Aires, Delhi, Hong Kong,Madrid, Barcelona, Munich, Heidelberg, Basingstoke, Melbourne, Paris,San Francisco, Seoul and Washington DC. For more information, please goto www.nature.com.
